Mutations

How Accurate Are At-Home COVID Tests With The XBB Subvariant?

Sat, 2023-01-14 00:54 — mike kraft

How Accurate Are At-Home COVID Tests With The XBB Subvariant? Experts have a few theories on why some people may be getting false negatives when they believe they have COVID. YahooNews

...

There aren’t any studies or pre-print reports currently available on how effective rapid tests are with XBB, but scientists predict that at-home tests will continue to work well with the latest crop of variants.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about How Accurate Are At-Home COVID Tests With The XBB Subvariant?
Log in or register to post comments

China's Covid cases touch 900 million, peak expected to last 2-3 months

Fri, 2023-01-13 16:46 — mike kraft

China COVID peak to last 2-3 months, hit rural areas next - expert The peak of China's COVID-19 wave is expected to last two to three months, and will soon swell over the vast countryside where medical resources are relatively scarce, a top Chinese epidemiologist has said. Bernard Orr,Ellen Zhang Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about China's Covid cases touch 900 million, peak expected to last 2-3 months
Log in or register to post comments

New Utah study affirms COVID vaccine is safe for kids

Fri, 2023-01-13 16:29 — mike kraft

New Utah study affirms COVID vaccine is safe for kids The study, co-authored by a doctor at Primary Children's Hospital, looked at 185 kids who suffered from MIS-C. Erin Alberty Axios

A new Utah-led study shows the COVID-19 vaccine didn't trigger dangerous responses in children who previously had a severe reaction to the virus itself.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New Utah study affirms COVID vaccine is safe for kids
Log in or register to post comments

Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases - CDC

Fri, 2023-01-13 16:25 — mike kraft

Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases - CDC The fast-spreading Omicron subvariant XBB.1.5 is estimated to account for 43% of the COVID-19 cases in the United States for the week ended Jan. 14, data from the Centers for Disease Control and Prevention showed on Friday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Omicron subvariant XBB.1.5 accounts for 43% of U.S. COVID cases - CDC
Log in or register to post comments

Convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find --study

Fri, 2023-01-13 01:02 — mike kraft

Study shows convalescent plasma works for immune-compromised Covid-19 patients, but it can be hard to find | CNN Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday. Elizabeth Cohen CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Paying people to take COVID vaccine worked well, European study

Fri, 2023-01-13 00:56 — mike kraft

Paying people to take COVID vaccine worked well, study finds Paying people to take a first COVID-19 vaccine dose didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors. CIDRAP

A study finds that paying people to take a first dose of a COVID-19 vaccine didn't lower the likelihood of seeking the second or third dose or of other positive health behaviors and didn't erode morals, sense of civic duty, or feelings of self-determination.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Paying people to take COVID vaccine worked well, European study
Log in or register to post comments

Reports very rare of Serious Adverse Events After Updated COVID-19 Booster Shots for Children--study

Fri, 2023-01-13 00:01 — mike kraft

CDC Study: Reports of Serious Adverse Events After Updated COVID-19 Booster Shot Among Children Rare The study said that the preliminary safety findings for the updated COVID-19 booster shot were ‘reassuring.’ Cecelia Smith-Schoenwalder US News & World Report

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Reports very rare of Serious Adverse Events After Updated COVID-19 Booster Shots for Children--study
Log in or register to post comments

Problems in Predicting How Long A Person Is Protected After a COVID Infection

Thu, 2023-01-12 15:17 — mike kraft

How Long Are You Protected After A COVID Infection Now? COVID cases are rising as the new XBB subvariant spreads. Are you at risk for reinfection if you recently had the virus? YahooNews

...

Exactly how long protection lasts after a COVID infection isn’t one-size-fits-all. A few factors make it impossible to say exactly how long you’re protected from reinfection.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Problems in Predicting How Long A Person Is Protected After a COVID Infection
Log in or register to post comments

Long Covid symptoms ease for most within a year-- new research

Thu, 2023-01-12 15:11 — mike kraft

'This will get better': Long Covid symptoms tend to ease within a year, new research finds Ongoing fatigue, loss of smell, weakness and trouble breathing can be scary and debilitating following Covid. A new study suggests most people do get better. NBC News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Long Covid symptoms ease for most within a year-- new research
Log in or register to post comments

WHO: XBB.1.5 Threatens to Increase COVID-19 Infections Globally, but data based only on U.S.

Thu, 2023-01-12 01:55 — mike kraft

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency CIDRAP

The World Health Organization (WHO) advisory group on virus evolution said the Omicron XBB.1.5 subvariant is poised to drive an increase in COVID-19 cases, but it cautioned that confidence in its assessment is low, because most of the information is based on data from just one country—the United States.

...

Country / Region Tags:

General Topic Tags: